aod9604 dosing frequency subcutaneous injection AOD 9604 Peptide for Fat Loss: Does It Work? December 4, 2024 Pharmacy Compounding

It falls under the S0 category of Non-Approved Substances, which is a catch-all classification for any pharmacological substance that isnt approved for human therapeutic use and is not addressed elsewhere on the list

Likewise, any published information relative to the dosing and administration of reference materials is made available strictly for reference and shall not be construed to encourage the self-administration or any human use of said reference materials

Like GLP-1 receptor agonists, this medication also works by sending satiety signals to your brain to reduce appetite and delay gastric emptying

Aged mice (22 months, equivalent to roughly 65 to 70 human years) treated with MOTS-c three times per week doubled their running capacity on treadmill tests

Research in preclinical models has explored its role in NNMT inhibition, NAD+ metabolism, and cellular energetics (pmc.ncbi.nlm.nih.gov, pubmed.ncbi.nlm.nih.gov)